Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE‐MRI

Abstract

DCE-MRI in locally advanced breast cancer has the potential to predict 5-year survival in a small patient cohort. In addition, changes in tumor vascularization after one cycle of NAC can be assessed.